Clinical Trial Update: A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir [Phase 4]

View source ↗

Summary

This Phase 4 pharmacokinetic study examines the pharmacokinetics of a triple protease inhibitor combination (indinavir, ritonavir, amprenavir) in HIV infection;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Agenerase (amprenavir)
• Crixivan (indinavir)
• Norvir (ritonavir)

Snippet

Sponsor: Emory University | Conditions: HIV Infections | Phase 4 | Status: COMPLETED